Use of aviptadil alone or in combination with alpha lipoic acid as a therapeutic medicament for post-viral infection syndrome
AssigneeAdvita Lifescience GmbH
InventorDorian BEVEC
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of Aviptadil or a functional derivative or a precursor thereof alone or in combination with Alpha Lipoic Acid or a functional derivative or a precursor thereof as (a) therapeutic agent(s) for the prophylaxis and/or treatment of a post-viral infection syndrome including, without limitation, fibrotic disease, inflammatory disease, neurodegenerative disease, autoimmune disease, or heart and vascular disease as a consequence of post-viral infection syndrome, such as a SARS-COV-2 infection. The invention further relates to the use of the therapeutic agent(s) for intravenous administration, or for oral administration, or for administration by inhalation.
Claims14
Aviptadil, a functional derivative or a precursor thereof, for use in the treatment of a post-viral infection syndrome.
Aviptadil, the functional derivative or precursor for use of any of the previous claims, the vector for use of any of the previous claims, the biological cell for use of any of the previous claims, the composition for use of any of the previous claims or the pharmaceutical product for use of any of the previous claims, for use in oral, intravenous, inhalation and/or intranasal treatment.
Aviptadil, the functional derivative or precursor for use of claim 10, the vector for use of claim 10, the biological cell for use of claim 10, the composition for use of claim 10 or the pharmaceutical product for use of claim 10, for use in intranasal treatment.
Aviptadil, the functional derivative or precursor for use of claim 11, the vector for use of claim 11, the biological cell for use of claim 11, the composition for use of claim 11 or the pharmaceutical product for use of claim 11, wherein the intranasal administration is direct nose-to-brain administration.
A method of treating sarcoidosis in a subject in need thereof, comprising administering an effective amount of Aviptadil to the subject via inhalation or via intravenous administration.
Dependencies are inferred from the claim text.